TABLE 3.

Recipient and Donor Characteristics at Primary LT and Re-LT in Patients With PSC

	Primary LT (n = 5080)	Re-LT (n = 629)	P Value	Early Re-LT (n = 151)	Late Re-LT (n = 478)	P Value
Age at LT, years	48 (38–57)	46 (36–55)	<0.001	42 (34–55)	46 (37–55)	0.10
Male sex	3453 (68.0)	458 (72.8)	0.01	104 (68.9)	354 (74.1)	0.21
Race/ethnicity			0.71			0.85
White	4168 (82.0)	518 (82.4)		126 (83.4)	392 (82.0)
Black	629 (12.4)	82 (13.0)		19 (12.6)	63 (13.2)
Hispanic	187 (3.7)	22 (3.5)		6 (4.0)	16 (3.3)
Asian	62 (1.2)	5 (0.8)		0	5 (1.0)
Other	33 (0.6)	2 (0.3)		0	2 (0.4)
Primary liver malignancy	106 (2.1)	4 (0.6)	0.01	1 (0.7)	3 (0.6)	>0.99
CCA	73 (1.4)	3 (0.5)	0.048	1 (0.7)	2 (0.4)	0.56
HCC	32 (0.6)	1 (0.2)	0.26	0 (0.0)	1 (0.2)	>0.99
Other	1 (<0.1)	0 (0.0)	>0.99	0 (0.0)	0 (0.0)
Location			<0.001			<0.001
In ICU	377 (7.4)	183 (29.1)		110 (72.8)	73 (15.3)
Hospitalized	804 (15.8)	177 (28.1)		30 (19.9)	147 (30.8)
Ambulatory	3897 (76.7)	269 (42.8)		11 (7.3)	258 (54.0)
Mechanical ventilation	100 (2.0)	102 (16.2)	<0.001	66 (43.7)	36 (7.5)	<0.001
MELD score*	19 (14–26)	25 (18–33)	<0.001	24 (16–31)	25 (19–33)	0.27
Total bilirubin, mg/dL	6.4 (2.7–15.0)	10.8 (3.3–24.2)	<0.001	8.6 (3.2–18.3)	11.8 (3.6–26.7)	0.02
Creatinine, mg/dL	0.9 (0.7–1.2)	1.3 (0.9–2.2)	<0.001	1.1 (0.8–2.4)	1.4 (0.9–2.1)	0.16
Albumin, g/L	3.0 (2.5–3.5)	2.8 (2.4–3.3)	<0.001	2.7 (2.3–3.2)	2.9 (2.4–3.3)	0.13
Living donor	551 (10.8)	8 (1.3)	<0.001	0 (0.0)	8 (1.7)	0.21
DCD donor	120 (2.4)	6 (1.0)	0.02	0 (0.0)	6 (1.3)	0.34
Donor age ≥ 60 years	620 (12.2)	59 (9.4)	0.04	17 (11.3)	42 (8.8)	0.36
Split graft	621 (12.2)	12 (1.9)	<0.001	1 (0.7)	11 (2.3)	0.31

NOTE: Data are given as n (%) or median (IQR).

^*Available for transplants performed after February 27, 2002 (n = 3175/5080, 442/629, 81/151, 361/478).